Skip to Main Content

Author Details

Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
2004
521
50
PMIDPaper TitleJournal TitlePublished Year
37355358European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study.Eur Urol2024
38014575Differences in overall survival of penile cancer patients versus population-based controls.Int J Urol2024
37661579The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer.Prostate2024
37743194European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.Eur Urol2024
37507248Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy.Eur Urol Focus2024
38042729Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage Analyses.Clin Genitourin Cancer2024
37981546Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients.Clin Genitourin Cancer2024
37874334[Androgen deprivation therapy and cardiovascular morbidity in prostate cancer: a narrative review].Urologie2024
37423774The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature.Eur Urol Oncol2024
37344282Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy.Clin Genitourin Cancer2024
35182370Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables.J Racial Ethn Health Disparities2023
37760467Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis.Cancers (Basel)2023
37721691In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery.Ann Surg Oncol2023
37755519Regional differences in clear cell metastatic renal cell carcinoma patients across the USA.World J Urol2023
37803241Impact of persistent PSA after salvage radical prostatectomy: a multicenter study.Prostate Cancer Prostatic Dis2023
37558516Conditional survival of stage III non-seminoma testis cancer patients.Urol Oncol2023
37704503Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium.Eur Urol Focus2023
37844332Radioligand Therapy With 177 Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer : Oncological Outcomes and Toxicity Profile.Clin Nucl Med2023
37787591Regional differences in metastatic urothelial carcinoma of the urinary bladder patients across the United States SEER registries.Can Urol Assoc J2023
37506474Regional differences in penile cancer patient characteristics and treatment rates across the United States.Cancer Epidemiol2023
37783172Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studys.Clinics (Sao Paulo)2023
37640983Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls.Int Urol Nephrol2023
37872250Characteristics of incidental prostate cancer in the United States.Prostate Cancer Prostatic Dis2023
37815682Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era.Ann Surg Oncol2023
37530661Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries.Minerva Urol Nephrol2023
35459985Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy.J Robot Surg2023
37221827Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence.Minerva Urol Nephrol2023
37024421Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients.Eur Urol Focus2023
37055323Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease Volume.Eur Urol Focus2023
36948042Regional differences in total hospital costs for radical cystectomy in the United States.Surg Oncol2023
37117107Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.Eur Urol2023
37051922Feasibility, acceptability, and behavioral outcomes of a multimodal intervention for prostate cancer patients: Experience from the MARTINI lifestyle program.Prostate2023
37046815Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma.Cancers (Basel)2023
36984452Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages.Medicina (Kaunas)2023
37043366African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients.Endocr Relat Cancer2023
37175005External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical Prostatectomy.Diagnostics (Basel)2023
37441347Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma.Eur Urol Open Sci2023
37374357Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy.Medicina (Kaunas)2023
37370733Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy.Cancers (Basel)2023
37464963Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy.Prostate2023
37003085Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.Eur J Cancer2023
37365054Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion.Clin Genitourin Cancer2023
37267581Reply to Z. Mai et al.J Clin Oncol2023
37032281Diagnostic Performance of <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results.Eur Urol Focus2023
36857638Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.J Clin Oncol2023
36656332Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?World J Urol2023
36813873Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.Int Urol Nephrol2023
36401949Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma.Cancer Epidemiol2023
36746729Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.Eur Urol Focus2023
36842919Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer.Eur Urol Focus2023
  • 1 - 50 of 521

Recommended Authors

Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 0
R Jeffrey Karnes
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 29
Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 29
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 32
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 11
Devin N Patel
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 5
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 4
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 11
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 10
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 14
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 17
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 7
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 8
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 5
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 30
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1999
Number of shared co-authors 13
Vincent J Gnanapragasam
University of Cambridge
Career Start Year 1999
Number of shared co-authors 12
Jim C Hu
Weill Cornell Medical Center
Career Start Year 1998
Number of shared co-authors 33
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 21
Philippe E Spiess
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 1996
Number of shared co-authors 16
Stephen J Freedland
Cedars-Sinai Medical Center
Career Start Year 1996
Number of shared co-authors 70
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 17
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 13
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 47
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 25
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 15

Collaborators

Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 203
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 135
Fred Saad
University of Montreal Health Center
Co-authored papers 134
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Co-authored papers 91
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Co-authored papers 56
Roderick C N van den Bergh
St. Antonius Hospital
Co-authored papers 38
Christopher P Evans
University of California Davis
Co-authored papers 26
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 19
Piet Ost
Ghent University, GZA Ziekenhuizen
Co-authored papers 19
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 18
Tobias Maurer
Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Co-authored papers 17
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Co-authored papers 16
Thorsten Schlomm
Charite - University Hospital Berlin
Co-authored papers 15
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
Anthony V D'Amico
Duke University Medical Center
Co-authored papers 13
Philip Cornford
Liverpool University Hospitals
Co-authored papers 12
Douglas S Scherr
New York-Presbyterian Hospital
Co-authored papers 11
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 11
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 10
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 9
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 9
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 8
Ming-Hui Chen
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 8
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 8
Amar U Kishan
University of California los angeles
Co-authored papers 7
Brian J Moran
Chicago Prostate Cancer Center
Co-authored papers 6
Jay P Ciezki
Cleveland Clinic
Co-authored papers 5
Trude B Wedde
Oslo University Hospital
Co-authored papers 5
Chandana A Reddy
Cleveland Clinic
Co-authored papers 5
Avinash Pilar
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 5
Release 1.2